Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ResearchAndMarkets.com's offering.
A new research publication examining the Autoimmune Disease Diagnostics Market has been released, offering comprehensive market insights, a competitive landscape, and a forecast extending to the year 2028.
The detailed analysis centers around the market segmentation by product, disease type, test, end-user, and geography, demonstrating expected steady growth driven by the rising prevalence of autoimmune disorders like rheumatoid arthritis, diabetes, and multiple sclerosis.
The Autoimmune Disease Diagnostics Market's trajectory is forecast to exhibit a robust compound annual growth rate (CAGR) of 5.53% from 2023 to 2028, culminating in a projected value of USD 6.41 billion by 2028. Factors such as the increased sensitivity of diagnostic tests, and the booming need for early disease diagnosis are recognized as pivotal contributors to the market's expansion.
Key Dynamics Influencing Market Growth
The surge in autoimmune disease prevalence is a significant force behind the escalating demand for diagnostics. The latest data showcases a notable increase in the incidence of diseases such as multiple sclerosis globally, with corresponding growth reflected in the diagnostics market. Furthermore, public awareness initiatives, such as the Autoimmune Disease Awareness Month, have been instrumental in enhancing understanding and driving early diagnoses.
These initiatives have successfully highlighted the importance of early detection and the critical role of diagnostics in disease management. However, the report acknowledges potential challenges, such as the high costs associated with autoimmune disease diagnostics and the prolonged time required for conclusive results, which may act as barriers to market growth.
Segment Analysis: Reagents & Kits Lead the Product Category
Reagents & Kits are projected to command a prominent share in the market due to their indispensable role in diagnostic testing. Factors such as ease of use, high sensitivity and specificity, along with FDA approvals for novel test kits, are poised to bolster the segment's growth through 2028. This segment's burgeon is further emphasized by continuous product innovation and approvals, creating a favorable climate for market progression.
Geographical Dominance: North America at the Forefront
The report forecasts North America to continue its dominion within the Autoimmune Disease Diagnostics Market. High awareness levels, governmental support, and an advanced healthcare infrastructure are identified as keystones to the region's market position, complemented by a considerable patient population requiring diagnostic services.
- In-depth analysis reveals that the region's prevalence of conditions such as arthritis and multiple sclerosis substantiates the need for diagnostic solutions.
- The data indicates an overwhelming necessity for autoimmune disease diagnostics, propelling North America's dominance in the market.
Key Market Players Spearheading Innovation
The analysis identifies key players who are shaping the landscape of the Autoimmune Disease Diagnostics Market with innovative solutions and strategic partnerships. Industry giants are recognized for their contributions to the evolving dynamics of the diagnostics sector, enabling advancements in early detection and disease management strategies. Recent developments by leading companies have further endorsed the market's growth, highlighting collaborations and launches aimed at enhancing autoimmune diagnostics. In conclusion, the detailed market report underlines the strategic imperatives shaping the Autoimmune Disease Diagnostics Market, providing an elaborate overview of market dynamics, segmental growth, and competitive landscapes, essential for stakeholders and industry participants anticipating market trends through 2028.
A selection of companies mentioned in this report includes
- Beckman Coulter, Inc.
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Thermofisher Scientific
- Werfen
- Bio-Rad Laboratories
- Exagen Inc.
- Grifols, S.A
- Medical & Biological Laboratories Co. Ltd.
- RSR Limited
- DiaSorin S.p.A
- Laboratory Corporation of America Holdings
- Abcam plc
- EUROIMMUN Medizinische Labordiagnostika AG
- Quest Diagnostics
- Hemagen Diagnostics, Inc.
- AESKU Diagnostics GmbH & Co. KG
- Trinity Biotech and Biomerieux SA.
For more information about this report visit https://www.researchandmarkets.com/r/2jiaf9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
